Combined transplantation of GDAsBMP and hr-decorin in spinal cord contusion repair

Neural Regeneration Research

Volumn 8, Issue 24, 2013, Pages 2236-2248

  Wu, Liang ^a,b   Li, Jian Jun ^a,b   Chen, Liang ^a,b   Zhang, Hong ^a   Yuan, Li ^a,b   Davies, Stephen J A ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA REHABILITATION RESEARCH CENTER   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Astrocytes; Brain derived growth factor; Combined transplantation; Glial cells; Glial fibrillary acidic protein; Glial progenitor cells; Glial scar; Grants supported paper; Human recombinant decorin; Neural regeneration; Neural stem cells; Neuroregeneration; Spinal cord injury

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4 INDUCED GLIAL RESTRICTED PRECURSOR DERIVED ASTROCYTE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN; PEPTIDES AND PROTEINS; RECOMBINANT DECORIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN 4; CYCLOSPORIN A; DECORIN; GLIAL FIBRILLARY ACIDIC PROTEIN; PLASMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DEATH; EMBRYO; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE HISTOCHEMISTRY; FLUORESCENCE MICROSCOPY; INFLAMMATION; MOTOR PERFORMANCE; NERVE FIBER; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SCAR FORMATION; SCORING SYSTEM; SPINAL CORD INJURY; SPINAL CORD REGENERATION; ASTROCYTE; ASTROCYTOSIS; EXPERIMENTAL SPINAL CORD CONTUSION; GLIAL PRECURSOR CELL; IMMUNOHISTOCHEMISTRY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; SENSORY NERVE CELL;

EID: 84886708002     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.24.003     Document Type: Article

References (63)

1. Fry EJ. Central nervous system regeneration: mission impossible? Clin Exp Pharmacol Physiol. 2001;28(4):253-258.
2. Park DH, Lee JH, Borlongan CV, et al. Transplantation of umbilical cord blood stem cells for treating spinal cord in-jury. Stem Cell Rev. 2011;7(1):181-194.
3. Liu J, Götherström C, Forsberg M, et al. Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immuno-genicity and immunomodulatory potentials in vitro. Stem Cell Res. 2013;10(3):325-337.
4. Kim JY, Kim DH, Kim JH, et al. Umbilical cord blood me-senchymal stem cells protect amyloid-β42 neurotoxicity via paracrine. World J Stem Cells. 2012;4(11):110-116.
5. Han X, Yang N, Cui Y, et al. Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and pro-motes functional recovery after spinal cord injury in the rat. Neurosci Lett. 2012;521(2):136-141.
6. Ozdemir M, Attar A, Kuzu I, et al. Stem cell therapy in spinal cord injury: in vivo and postmortem tracking of bone marrow mononuclear or mesenchymal stem cells. Stem Cell Rev. 2012;8(3):953-962.
7. Wiliams RR, Bunge MB. Schwann cell transplantation: a repair strategy for spinal cord injury? Prog Brain Res. 2012;201:295-312.
8. Hill CE, Brodak DM, Bartlett Bunge M. Dissociated prede-generated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on re-generation and functional recovery compared to schwann cell transplants. J Neurotrauma. 2012;29(12):2226-2243.
9. Joosten EA, Veldhuis WB, Hamers FP. Collagen contain-ing neonatal astrocytes stimulates regrowth of injured fi-bers and promotes modest locomotor recovery after spin-al cord injury. J Neurosci Res. 2004;7(1):127-142.
10. Fan C, Zheng Y, Cheng X, et al. Transplantation of D15A-expressing glial-restricted-precursor-derived astro-cytes improves anatomical and locomotor recovery after spinal cord injury. Int J Biol Sci. 2013;9(1):78-93.
11. Radtke C, Kocsis JD. Peripheral nerve injuries and trans-plantation of olfactory ensheathing cells for axonal rege-neration and remyelination: factor fiction? Int J Mol Sci. 2012;13(10):12911-12924.
12. Yazdani SO, Pedram M, Hafizi M, et al. A comparison be-tween neurally induced bone marrow derived mesenchymal stem cells and olfactory ensheathing glial cells to repair spin-al cord injuries in rat. Tissue Cell. 2012;44(4):205-213.
13. Roet KC, Eggers R, Verhaagen J. Noninvasive biolumi-nescence imaging of olfactory ensheathing glia and schwann cells following transplantation into the lesioned rat spinal cord. Cell Transplant. 2012;21(9):1853-1865.
14. Li BC, Xu C, Zhang JY, et al. Differing Schwann cells and olfactory ensheathing cells behaviors, from interacting with astrocyte, produce similar improvements in contused rat spinal cord's motor function. J Mol Neurosci. 2012; 48(1):35-44.
15. Sharp J, Keirstead HS. Therapeutic applications of oligo-dendrocyte precursors derived from human embryonic stem cells. Curr Opin Biotechnol. 2007;18(5):434-440.
16. Sharp J, Frame J, Siegenthaler M, et al. Human embryo-nic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord in-jury. Stem Cells. 2010;28(1):152-163.
17. Bazley FA, Pourmorteza A, Gupta S, et al. DTI for as-sessing axonal integrity after contusive spinal cord injury and transplantation of oligodendrocyte progenitor cells. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:82-85.
18. Piao JH, Wang Y, Duncan ID. CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord. Glia. 2013;61(3):361-367.
19. Rajasekaran S, Kanna RM, Shetty AP, et al. Efficacy of diffusion tensor anisotropy indices and tractography in assessing the extent of severity of spinal cord injury: an in vitro analytical study in calf spinal cords. Spine J. 2012; 12(12):1147-1153.
20. Valsasina P, Rocca MA, Absinta M, et al. Cervical cord FMRI abnormalities differ between the progressive forms of mul-tiple sclerosis. Hum Brain Mapp. 2012;33(9):2072-2080.
21. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res. 2007;161:125-141.
22. Davies SJ, Fitch MT, Memberg SP, et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 1997;390(6661):680-683.
23. Shechter R, Raposo C, London A, et al. The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One. 2011;6(12):e27969.
24. Parry PV, Engh JA. Promotion of neuronal recovery fol-lowing experimental SCI via direct inhibition of glial scar formation. Neurosurgery. 2012;70(6):N10-11.
25. Wu J, Pajoohesh-Ganji A, Stoica BA, et al. Delayed ex-pression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion. J Neuroinflammation. 2012;9:169.
26. Kuerten S, Gruppe TL, Laurentius LM, et al. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. APMIS. 2011;119(6):336-346.
27. De Winter F, Oudega M, Lankhorst AJ, et al. In-jury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol. 2002;175(1):61-75.
28. Tang X, Davies JE, Davies SJ. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and te-nascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res. 2003;71(3):427-444.
29. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an an-tigen for monoclonal antibody IN-1. Nature. 2000; 403(6768):434-439.
30. Wang KC, Koprivica V, Kim JA, et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002;417(6892):941-944.
31. Zendedel A, Nobakht M, Bakhtiyari M, et al. Stromal cell-derived factor-1 alpha (SDF-1α) improves neural re-covery after spinal cord contusion in rats. Brain Res. 2012; 1473:214-226.
32. Han SS, Liu Y, Tyler-Polsz C, et al. Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential mi-gration in white matter. Glia. 2004;45(1):1-16.
33. Hill CE, Proschel C, Noble M, et al. Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion en-vironment and axonal regeneration. Exp Neurol. 2004; 190(2):289-310.
34. Hofstetter CP, Holmstrom NA, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8(3):346-353.
35. Giménez y Ribotta M, Menet V, Privat A. The role of as-trocytes in axonal regeneration in the mammalian CNS. Prog Brain Res. 2001;132:587-610.
36. Hobohm C, Günther A, Grosche J, et al. Decompsition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res. 2005;80(4):539-548.
37. Gregori N, Proschel C, Noble M, et al. The tripotential gli-al-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J Neurosci. 2002;22(1):248-256.
38. Liu Y, Wu Y, Lee JC, et al. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia. 2002;40(1): 25-43.
39. Phillips AW, Falahati S, De Silva R, et al. Derivation of glial restricted precursors from E13 mice. J Vis Exp. 2012; (64):3462.
40. Davies JE, Huang C, Proschel C, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol. 2006;5(3):7.
41. Schachtrup C, Ryu JK, Helmrick MJ, et al. Fibrinogen triggers astrocyte scar formation by promoting the availa-bility of active TGF-β after vascular damage. J Histochem Cytochem. J Neurosci. 2010;30(17):5843-5854.
42. Kritis A, Kapoukranidou D, Michailidou B, et al. Sciatic nerve crush evokes a biphasic TGF-beta and decorin modulation in the rat spinal cord. Hippokratia. 2010;14(1): 37-41.
43. Hanemann CO, Kuhn G, Lie A, et al. Expression of deco-rin mRNA in the nervous system of rat. J Histochem Cy-tochem. 1993;41(9):1383-1391.
44. Davies JE, Tang X, Bournat JC, et al. Decorin promotes plasminogen/plasmin expression within acute spinal cord injuries and by adult microglia in vitro. J Neurotrauma. 2006;23(3-4):397-408.
45. Minor KH, Bournat JC, Toscano N, et al. Decorin, eryt-hroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regula-tion of semaphorin 3A in central nervous system scar tis-sue. Brain. 2011;134(Pt 4):1140-1155.
46. Minor K, Tang X, Kahrilas G, et al. Decorin promotes ro-bust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons. Neurobiol Dis. 2008;32(1):88-95.
47. Rao MS, Noble M, Mayer-Pröschel M. A tripotential glial precursor cell is present in the developing spinal cord. Proc. Proc Natl Acad Sci U S A. 1998;95(7):3996-4001.
48. Rao MS, Mayer-Proschel M. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biol. 1997;188(1):48-63.
49. Mayer-Proschel M, Kalyani AJ, Mujtaba T, et al. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron. 1997;19(4):773-785.
50. Ben-Hur T, Rogister B, Murray K, et al. Growth and fate of PSA-NCAM+ precursors of the postnatal brain. J Neurosci. 1998;18(15):5777-5788.
51. Mujtaba T, Piper DR, Kalyani A, et al. Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol. 1999;214(1): 113-127.
52. Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002;40(1):65-77.
53. Lepore AC, O'Donnell J, Kim AS, et al. Human gli-al-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One. 2011;6(10):e25968.
54. Sandrock RW, Wheatley W, Levinthal C, et al. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurologi-cal disorders. Regen Med. 2010;5(3):381-394.
55. Baptiste DC, Tighe A, Fehlings MG. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury. Expert Opin Investig Drugs. 2009; 18(5):663-673.
56. Noble M, Davies JE, Mayer-Pröschel M, et al. Precursor cell biology and the development of astrocyte transplanta-tion therapies: lessons from spinal cord injury. Neurothe-rapeutics. 2011;8(4):677-693.
57. Haas C, Neuhuber B, Yamagami T, et al. Phenotypic analysis of astrocytes derived from glial restricted pre-cursors and their impact on axon regeneration. Exp Neu-rol. 2012;233(2):717-732.
58. Kobayashi NR, Fan DP, Giehl KM, et al. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci. 1997;17 (24):9583-9595.
59. Fukui N, Fukuda A, Kojima K, et al. Suppression of fibrous adhesion by proteoglycan decorin. J Orthop Res. 2001; 19(3):456-462.
60. Davies JE, Tang X, Denning JW, et al. Decorin sup-presses neurocan, brevican, phosphacan and NG2 ex-pression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci. 2004;19(5):1226-1242.
61. Anderson AJ, Robert S, Huang W, et al. Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma. 2004;21(12):1831-1846.
62. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12(1):1-21.
63. Zhou HL, Yang HJ, Li YM, et al. Changes in glial cell line-derived neurotrophic factor expression in the rostral and caudal stumps of the transected adult rat spinal cord. Neurochem Res. 2008;33(5):927-937.